(Q67540101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

J. A. Kanis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A832019

31 July 2022

R. G. Russell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A832019

31 July 2022

language of work or name

English

0 references

publication date

1 January 1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

8 January 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=832019

full work available at URL

31 July 2022

https://europepmc.org/articles/PMC1604081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A832019

https://europepmc.org/articles/PMC1604081?pdf=render

31 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A832019

31 July 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

78-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

6053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy

14 September 2019

cites work

1 reference

12 December 2020

1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism

1 reference

12 December 2020

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

1 reference

12 December 2020

Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.6053.78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:832019%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference